Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Imaging and intervention in thyroid lesions

2nd ecancer – TMC Kolkata Oncology Congress

30 Sep - 1 Oct 2023

Published: 9 Oct 2023

Views: 55

Rating:

Save

Dr Dayanand Lingegowda - Tata Medical Center, Kolkata,India

Dr Dayanand Lingegowda, speaks at the 2nd ecancer TMC Oncology Congress, which was held at the Tata Medical Center, Kolkata, on 31 September and 1 October 2023.

Related Videos

Multiple Myeloma: evolving paradigm - Panel Discussion

Moderator: Dr Dibeyndu De/Panelists: Dr Amit Kumar, Dr Sunil Dharmani, Dr...

Multiple Myeloma: evolving paradigm - Panel Discussion ( Moderator: Dr Dibeyndu De/Panelists: Dr Amit Kumar, Dr Sunil Dharmani, Dr Siddharth Nanda AIIMS, Dr Avinash Tiwari, Dr Rudra Pratap, Dr Siddharth Turkar )

Myeloma treatment and prognosis

Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine...

Myeloma treatment and prognosis ( Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine, Kolkata, India )

How to approach a breast lump and nipple discharge

Prof Anand Mishra - KGMU, Lucknow,India

How to approach a breast lump and nipple discharge ( Prof Anand Mishra - KGMU, Lucknow,India )

Axillary management in breast

Dr Sanjit Agrawal, TMC, Kolkata

Axillary management in breast ( Dr Sanjit Agrawal, TMC, Kolkata )

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru

The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in...

Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )

Hypofractionated high dose intensity modulated radiotherapy non-inferior for...

Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK

$Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer ( Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK )$

The advancements in radiotherapy for breast cancer patients

Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia

The advancements in radiotherapy for breast cancer patients ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )

More from ecancer